Evidence map›Paper›PMID 32186508›Full record

ArticleEmerging infectious diseases2020

Multicenter Study of Azole-Resistant Aspergillus fumigatus Clinical Isolates, Taiwan

Chi-Jung Wu, Wei-Lun Liu, Chih-Cheng Lai, Chien-Ming Chao, Wen-Chien Ko, Hsuan-Chen Wang, Ching-Tzu Dai, Ming-I Hsieh, Pui-Ching Choi, Jia-Ling Yang and 1 more

Abstract readMulticenter Study
In one paragraph

Article in Emerging infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Understanding multi-azole resistance inFrontiers in fungal biology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Azole Resistance andJournal of fungi (Basel, Switzerland) · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Studies in mycology · 2021
    Review
  15. Article
  16. Article
  17. Review
  18. A Cyp51B Mutation Contributes to Azole Resistance inJournal of fungi (Basel, Switzerland) · 2020
    Article
  19. Journal of fungi (Basel, Switzerland) · 2020
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Chi-Jung Wu
Wei-Lun Liu
Chih-Cheng Lai
Chien-Ming Chao
Wen-Chien Ko
Hsuan-Chen Wang
Ching-Tzu Dai
Ming-I Hsieh
Pui-Ching Choi
Jia-Ling Yang
Yee-Chun Chen

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In a multicenter study, we determined a prevalence rate of 4% for azole-resistant Aspergillus fumigatus in Taiwan. Resistance emerged mainly from the environment (TR

Indexed as

Aspergillus fumigatusAzolesAntifungal AgentsDrug Resistance, FungalFungal ProteinsMicrobial Sensitivity TestsTaiwanAntifungal AgentsAzolesFungal Proteinsantimicrobial resistanceAspergillus fumigatusazole resistanceazole usecdr1Bclinical isolatescyp51AenvironmentsfungiHMG-CoA reductasehumansTaiwanTR34/L98HTR46/Y121F/T289A

Identifiers

PMID32186508
PMCPMC7101115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.